產(chǎn)品供應(yīng)鹽酸阿霉素

  • 發(fā)布日期:2024-03-22
  • 有效期限:30天
湖北健文生物醫(yī)藥有限公司 VIP
246-818-3
C27H30ClNO11
579.9802

詳細(xì)信息
  • ;鹽酸多柔比星;(8S-cis)-10-((3-氨基-2,3,6-三去氧-a-L-來(lái)蘇己吡喃基)-氧)-7,8,9,10-四氫-6,8,11-三羥基-8-羥基乙;-1-甲氧基-5,12-并四苯二酮鹽酸鹽;鹽酸多柔吡星;(8S-cis)-10-[(3-氨基-2,3,6-三去氧-a-L-來(lái)蘇己吡喃基)-氧]-7,8,9,10-四氫-6,8,11-三羥基-8-羥基乙;-1-甲氧基-5,12-并四苯二酮鹽酸鹽;
  • doxorubicin hydrochloride
  • ;Doxorubicin, HCl;(8s-cis)-10-((3-amino-2,3,6-trideoxy-alpha-l-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxynaphthacene-5,12-dione hydrochloride;(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxyhexopyranoside hydrochloride (1:1);(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside hydrochloride (1:1);Doxorubicin HCL;Doxourbicin HCl;
  • InChI=1/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1
  • 216℃
  • 810.3°C at 760 mmHg
  • 443.8°C
  • CAS NO:25316-40-9

免責(zé)聲明:以上所展示的信息由企業(yè)自行提供,內(nèi)容的真實(shí)性、準(zhǔn)確性和合法性由發(fā)布企業(yè)負(fù)責(zé),化工網(wǎng)對(duì)此不承擔(dān)任何保證責(zé)任。我們?cè)瓌t上建議您選擇化工網(wǎng)高級(jí)會(huì)員或VIP會(huì)員。